Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;1862(12):2244-2252.
doi: 10.1016/j.bbadis.2016.05.005. Epub 2016 May 8.

Cellular mechanisms and consequences of glycation in atherosclerosis and obesity

Raquel López-Díez  1 , Alexander Shekhtman  2 , Ravichandran Ramasamy  1 , Ann Marie Schmidt  3
Affiliations
Review

Cellular mechanisms and consequences of glycation in atherosclerosis and obesity

Raquel López-Díez et al. Biochim Biophys Acta. 2016 Dec.

Abstract

Post-translational modification of proteins imparts diversity to protein functions. The process of glycation represents a complex set of pathways that mediates advanced glycation endproduct (AGE) formation, detoxification, intracellular disposition, extracellular release, and induction of signal transduction. These processes modulate the response to hyperglycemia, obesity, aging, inflammation, and renal failure, in which AGE formation and accumulation is facilitated. It has been shown that endogenous anti-AGE protective mechanisms are thwarted in chronic disease, thereby amplifying accumulation and detrimental cellular actions of these species. Atop these considerations, receptor for advanced glycation endproducts (RAGE)-mediated pathways downregulate expression and activity of the key anti-AGE detoxification enzyme, glyoxalase-1 (GLO1), thereby setting in motion an interminable feed-forward loop in which AGE-mediated cellular perturbation is not readily extinguished. In this review, we consider recent work in the field highlighting roles for glycation in obesity and atherosclerosis and discuss emerging strategies to block the adverse consequences of AGEs. This article is part of a Special Issue entitled: The role of post-translational protein modifications on heart and vascular metabolism edited by Jason R.B. Dyck & Jan F.C. Glatz.

Keywords: Atherosclerosis; Diabetes; Glycation; Obesity; Receptor for advanced glycation end products; Theraepeutics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The mechanisms of RAGE ligands formation, accumulation and signal transduction. The observation that AGE-RAGE suppresses expression of GLO1 (Glyoxalase 1) suggests that RAGE is both a mechanism for triggering RAGE ligand AGE signal transduction (and cellular consequences) and serves as a feed forward loop to increase AGE production and accumulation.
Figure 2
Figure 2
The mechanisms of soluble RAGE production by cell surface cleavage (by MMPs and ADAM10) and by alternative splicing (formation of esRAGE).
See this image and copyright information in PMC

References

    1. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 1995;34:10872–10878. - PubMed
    1. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest. 1993;91:2463–2469. doi: 10.1172/jci116481. - PMC - PubMed
    1. Garlick RL, Mazer JS, Chylack LT, Jr., Tung WH, Bunn HF. Nonenzymatic glycation of human lens crystallin. Effect of aging and diabetes mellitus. J Clin Invest. 1984;74:1742–1749. doi: 10.1172/jci111592. - PMC - PubMed
    1. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003;21:3–12. doi: 10.1097/01.hjh.0000042892.24999.92. - PubMed
    1. Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, Ahmed MU, Reddy S, Zyzak DV, Thorpe SR, Baynes JW. New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant. 1996;11(Suppl 5):41–47. - PubMed

Publication types

MeSH terms

Substances